Firefly Neuroscience (AIFF) Return on Sales (2010 - 2026)

Firefly Neuroscience's Return on Sales history runs 16 years deep, the most recent figure standing at 0.04% for Q1 2026.

• In Q1 2026, Return on Sales rose 297.0% year-over-year to 0.04%; the TTM figure through Mar 2026 stood at 0.06% (up 170.0% YoY), while the FY2025 annual figure was 0.17%, up 79.0% from the prior year.
• Return on Sales was 0.04% for Q1 2026 at Firefly Neuroscience, up from 0.06% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.0% in Q2 2022 to a low of 3.01% in Q1 2025.
• Historically, Return on Sales has averaged 0.33% across 5 years, with a median of 0.03% in 2026.
• The sharpest annual moves came in 2024 and 2026: Return on Sales tumbled 129 bps in 2024, then jumped 297 bps in 2026.
• A 5-year view of Return on Sales shows it stood at 0.04% in 2022, then soared by 101 bps to 0.0% in 2023, then tumbled by 481762 bps to 1.3% in 2024, then soared by 95 bps to 0.06% in 2025, then soared by 31 bps to 0.04% in 2026.
• The last three Return on Sales figures came in at 0.04% (Q1 2026), 0.06% (Q4 2025), and 0.07% (Q3 2025), per Business Quant data.